A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions.

BACKGROUND ViziLite Plus with TBlue system (Zila Pharmaceuticals; now Zila, a division of Tolmar, Fort Collins, Colo.) and VELscope (LED Dental, White Rock, British Columbia, Canada) are oral cancer screening aids that have been developed to assist dentists in identifying precancerous and cancerous oral lesions. METHODS The authors screened patients with an overhead examination light and then with VELscope or ViziLite. Patients with a clinically innocuous lesion underwent a biopsy, and the authors compared the results of tissue pathological analysis with findings from the screening aid tests to determine the sensitivity and specificity of each device. The authors tested these devices to determine their ability to aid in the decision-making process regarding whether further evaluation of a clinically innocuous lesion was required. RESULTS The authors examined 102 lesions with ViziLite and then biopsied them [corrected]. They found three dysplasias and one malignancy, none of which were detected with the ViziLite (sensitivity = 0 percent, confidence interval [CI] = 0-60.2 percent; specificity = 75.5 percent, CI = 66.7-82.8 percent). The authors examined another 156 lesions with VELscope and then biopsied them [corrected].They found 11 dysplasias and one malignancy, six of which were detected with VELscope (sensitivity = 50 percent, CI = 21.1-78.9 percent; specificity = 38.9 percent, CI = 30.8-46.9 percent). CONCLUSIONS The study results indicate that use of ViziLite or VELscope along with a conventional screening examination for lesions deemed clinically innocuous was not beneficial in identifying dysplasia or cancer. Additional clinical studies are needed before these devices can be recommended. CLINICAL IMPLICATIONS Clinicians and patients could have a false sense of security after obtaining a negative ViziLite or VELscope examination result because potentially large numbers of precancerous and cancerous lesions will be missed by both devices.

[1]  Autofluorescence in normal and malignant human oral tissues and in DMBA-induced hamster buccal pouch carcinogenesis. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2]  J. Epstein,et al.  Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. , 2007, Oral oncology.

[3]  P. Speight,et al.  Critical Evaluation of Diagnostic Aids for the Detection of Oral Cancer , 2008 .

[4]  Camile S Farah,et al.  A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions. , 2007, Oral oncology.

[5]  Sensitivity of direct tissue fluorescence visualization in screening for oral premalignant lesions in general practice. , 2009, General dentistry.

[6]  J. Epstein,et al.  Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. , 2006, The Journal of clinical dentistry.

[7]  H. Nagatsuka,et al.  Angiogenic Squamous Dysplasia in Oral Epithelial Dysplastic Lesions , 2005 .

[8]  S. Boxer,et al.  On the Origin of Heme Absorption Band Shifts and Associated Protein Structural Relaxation in Myoglobin following Flash Photolysis* , 1997, The Journal of Biological Chemistry.

[9]  Ben Balevi,et al.  Evidence-based decision making: should the general dentist adopt the use of the VELscope for routine screening for oral cancer? , 2007, Journal.

[10]  L. Patton,et al.  Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. , 2008, Journal of the American Dental Association.

[11]  P. N. Robinson,et al.  Early diagnosis of oral cavity cancers. , 2006, Otolaryngologic clinics of North America.

[12]  J. Sciubba.  Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group. , 1999, Journal of the American Dental Association.

[13]  Mahendra Kumar,et al.  Prevalence of oral pre-malignant and malignant lesions at a tertiary level hospital in Allahabad, India. , 2008, Asian Pacific journal of cancer prevention : APJCP.

[14]  D. Laskin,et al.  Efficacy of the ViziLite system in the identification of oral lesions. , 2007, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[15]  K Svanberg,et al.  In vivo fluorescence imaging for tissue diagnostics. , 1997, Physics in medicine and biology.

[16]  Haishan Zeng,et al.  Simple device for the direct visualization of oral-cavity tissue fluorescence. , 2006, Journal of biomedical optics.

[17]  Rebecca Richards-Kortum,et al.  Understanding the Biological Basis of Autofluorescence Imaging for Oral Cancer Detection: High-Resolution Fluorescence Microscopy in Viable Tissue , 2008, Clinical Cancer Research.

[18]  J. Epstein,et al.  The efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesions. , 2006, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.